Literature DB >> 11330425

Cholecystokinin (CCK) secretion in patients with severe short bowel syndrome (SSBS).

P R Ling1, M Sheikh, P Boyce, M Keane-Ellison, A Thibault, P Burke, S Freedman, B R Bistrian.   

Abstract

This study examined the effects of a liquid meal on cholecystokinin (CCK) secretion in patients with severe short bowel syndrome (SSBS) receiving home total parenteral nutrition (TPN) support for 5-19 years after massive small bowel resection. Five patients with SSBS due to superior mesenteric artery or vein thrombosis were included. Five healthy volunteers served as controls. Blood was drawn before and 1 hr following consumption of 250 ml of a liquid diet containing 232 kcal with 8 g fat and 8 g protein. Plasma CCK activity was evaluated by amylase bioassay. All patients had stable weight with a normal BMI and serum albumin level, although there were mild abnormalities in their liver function tests. CCK secretion after stimulation was significantly decreased in patients. These results suggest that reduction in intestinal length influences CCK secretion in response to meal stimulation in SSBS patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11330425     DOI: 10.1023/a:1010772922341

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

1.  Blood carnitine status after orthotopic liver transplantation in patients with end-stage liver disease.

Authors:  J D Palombo; P R Borum; R L Jenkins; C Trey; B R Bistrian
Journal:  Am J Clin Nutr       Date:  1989-09       Impact factor: 7.045

2.  Does total parenteral nutrition induce gallbladder sludge formation and lithiasis?

Authors:  B Messing; C Bories; F Kunstlinger; J J Bernier
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

3.  Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.

Authors:  R A Liddle; I D Goldfine; M S Rosen; R A Taplitz; J A Williams
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

4.  Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition.

Authors:  S Chan; K C McCowen; B R Bistrian; A Thibault; M Keane-Ellison; R A Forse; T Babineau; P Burke
Journal:  Surgery       Date:  1999-07       Impact factor: 3.982

5.  The effect of gastrointestinal hormones on the gastric microcirculation.

Authors:  P H Guth; E Smith
Journal:  Gastroenterology       Date:  1976-09       Impact factor: 22.682

6.  Gall bladder sludge formation during prolonged fasting after gastrointestinal tract surgery.

Authors:  L Bolondi; S Gaiani; S Testa; G Labò
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

7.  Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation.

Authors:  A L Buchman; M D Dubin; A A Moukarzel; D J Jenden; M Roch; K M Rice; J Gornbein; M E Ament
Journal:  Hepatology       Date:  1995-11       Impact factor: 17.425

8.  The addition of lipids increases the total parenteral nutrition-associated cholestasis in the rat.

Authors:  G C La Scala; C Le Coultre; B G Roche; P Bugmann; D C Belli
Journal:  Eur J Pediatr Surg       Date:  1993-08       Impact factor: 2.191

9.  Gallstone disease in patients with severe short bowel syndrome dependent on parenteral nutrition.

Authors:  N Manji; B R Bistrian; E A Mascioli; P A Benotti; G L Blackburn
Journal:  JPEN J Parenter Enteral Nutr       Date:  1989 Sep-Oct       Impact factor: 4.016

10.  Increasing dextrose concentrations in total parenteral nutrition (TPN) causes alterations in hepatic morphology and plasma levels of insulin and glucagon in rats.

Authors:  S Li; M S Nussbaum; D Teague; C L Gapen; R Dayal; J E Fischer
Journal:  J Surg Res       Date:  1988-06       Impact factor: 2.192

View more
  1 in total

Review 1.  Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.

Authors:  Marc J Berna; Robert T Jensen
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.